ONCY
Oncolytics Biotech
ONCY
ONCY
32 hedge funds and large institutions have $2.11M invested in Oncolytics Biotech in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
Holders
32
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$128K | |
| 2 | +$101K | |
| 3 | +$19.2K | |
| 4 |
BAM
Brave Asset Management
Summit,
New Jersey
|
+$16.6K |
| 5 |
IAIM
International Assets Investment Management
Orlando,
Florida
|
+$10.5K |
Top Sellers
| 1 | -$375K | |
| 2 | -$156K | |
| 3 | -$105K | |
| 4 |
VF
Virtu Financial
New York
|
-$28K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$22.2K |